149 related articles for article (PubMed ID: 3896154)
1. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
[TBL] [Abstract][Full Text] [Related]
4. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
Furue H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
Chaplinski T; Laszlo J; Moore J; Silverman P
Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
[TBL] [Abstract][Full Text] [Related]
10. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
Kimura K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
Sarna G; Figlin R; McCarthy S
J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
[TBL] [Abstract][Full Text] [Related]
12. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of human leukocyte interferon in patients with advanced cancer.
Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of a synthetic mutant of beta-interferon.
Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
[TBL] [Abstract][Full Text] [Related]
15. [Phase I study of a recombinant gamma interferon (S-6810)].
Ogawa M; Takaku F; Maekawa T; Ota K; Ichimaru M; Izuo M; Takakura K; Ikeda S; Koiso K; Machida T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma.
Kempf RA; Grunberg SM; Daniels JR; Skinner DG; Venturi CL; Spiegel R; Neri R; Greiner JM; Rudnick S; Mitchell MS
J Biol Response Mod; 1986 Feb; 5(1):27-35. PubMed ID: 3958753
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
[TBL] [Abstract][Full Text] [Related]
19. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Laszlo J
J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
